-
Signature
-
/s/ Randall K. Fields
-
Issuer symbol
-
TRAK
-
Transactions as of
-
14 Jan 2026
-
Net transactions value
-
-$82,428
-
Form type
-
4
-
Filing time
-
16 Jan 2026, 16:30:02 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| FIELDS RANDALL K |
CHIEF EXECUTIVE OFFICER, Director, 10%+ Owner |
5282 S COMMERCE DRIVE, SUITE D-292, MURRAY |
/s/ Randall K. Fields |
16 Jan 2026 |
0001143335 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
TRAK |
Common Stock |
Sale |
$11,094 |
-1,000 |
-0.66% |
$11.09 |
151,500 |
14 Jan 2026 |
By RK Fields Charitable 2022, LLC |
F1, F2 |
| transaction |
TRAK |
Common Stock |
Sale |
$39,883 |
-3,600 |
-2.4% |
$11.08 |
147,900 |
15 Jan 2026 |
By RK Fields Charitable 2022, LLC |
F1, F3 |
| transaction |
TRAK |
Common Stock |
Sale |
$31,451 |
-2,900 |
-2% |
$10.85 |
145,000 |
16 Jan 2026 |
By RK Fields Charitable 2022, LLC |
F1, F4 |
| holding |
TRAK |
Common Stock |
|
|
|
|
|
3,483,955 |
14 Jan 2026 |
Direct |
|
| holding |
TRAK |
Common Stock |
|
|
|
|
|
615,260 |
14 Jan 2026 |
By Riverview Financial Corp. |
|
| holding |
TRAK |
Common Stock |
|
|
|
|
|
30,667 |
14 Jan 2026 |
By Spouse |
|
| holding |
TRAK |
Common Stock |
|
|
|
|
|
333,643 |
14 Jan 2026 |
By Fields Management, Inc. |
|
| holding |
TRAK |
Series B Preferred Stock |
|
|
|
|
|
169,797 |
14 Jan 2026 |
By Riverview Financial Corp |
|
| holding |
TRAK |
Series B Preferred Stock |
|
|
|
|
|
3,704 |
14 Jan 2026 |
By Spouse |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: